Bionano Genomics, Inc.

Bionano Genomics, Inc.verified

BNGO

Price:

$0.75

Market Cap:

$51.83M

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-g...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2018-08-21

Stock Exchange

NASDAQ

Ticker

BNGO

The PE Ratio as of June 2024 (TTM) for Bionano Genomics, Inc. (BNGO) is -0.12

According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.12. This represents a change of -80.10% compared to the average of -0.60 of the last 4 quarters.

Bionano Genomics, Inc. (BNGO) Historical PE Ratio (quarterly & annually)

How has BNGO PE Ratio performed in the past?

The mean historical PE Ratio of Bionano Genomics, Inc. over the last ten years is -3.47. The current -0.12 PE Ratio has changed 246.11% with respect to the historical average. Over the past ten years (40 quarters), BNGO's PE Ratio was at its highest in in the September 2023 quarter at -0.24. The PE Ratio was at its lowest in in the March 2021 quarter at -53.60.

Quarterly (TTM)
Annual

Average

-3.47

Median

-1.86

Minimum

-11.43

Maximum

-0.28

Bionano Genomics, Inc. (BNGO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bionano Genomics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.15%

Maximum Annual PE Ratio = -0.28

Minimum Annual Increase = -91.28%

Minimum Annual PE Ratio = -11.43

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.28-91.28%
2022-3.18-72.13%
2021-11.4346.37%
2020-7.811.15%
2019-0.62-68.95%
2018-2.00182.01%
2017-0.71-58.32%

Bionano Genomics, Inc. (BNGO) Average PE Ratio

How has BNGO PE Ratio performed in the past?

The current PE Ratio of Bionano Genomics, Inc. (BNGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.96

5-year avg

-4.66

10-year avg

-3.47

Bionano Genomics, Inc. (BNGO) PE Ratio vs. Peers

How is BNGO’s PE Ratio compared to its peers?

Bionano Genomics, Inc.’s PE Ratio is less than Intuitive Surgical, Inc. (76.93), greater than Innovative Eyewear, Inc. (-0.65), greater than Stereotaxis, Inc. (-7.52), greater than NEXGEL, Inc. (-4.02), greater than Microbot Medical Inc. (-1.43), less than STAAR Surgical Company (130.28), greater than Envista Holdings Corporation (-24.86), less than G Medical Innovations Holdings Ltd (0), less than Becton, Dickinson and Company (51.75), less than West Pharmaceutical Services, Inc. (43.01), less than ResMed Inc. (31.56), greater than Wearable Health Solutions, Inc. (-1.23), less than BioLife Sciences Inc. (0), greater than Psykey, Inc. (-4.01), greater than Predictive Oncology Inc. (-0.25), greater than Sharps Technology, Inc. (-0.58), greater than GlucoTrack, Inc. (-2.55), less than Meihua International Medical Technologies Co., Ltd. (1.12),

Build a custom stock screener for Bionano Genomics, Inc. (BNGO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bionano Genomics, Inc. (BNGO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bionano Genomics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Bionano Genomics, Inc. (BNGO)?

What is the highest PE Ratio for Bionano Genomics, Inc. (BNGO)?

What is the 3-year average PE Ratio for Bionano Genomics, Inc. (BNGO)?

What is the 5-year average PE Ratio for Bionano Genomics, Inc. (BNGO)?

How does the current PE Ratio for Bionano Genomics, Inc. (BNGO) compare to its historical average?